1,175
Views
44
CrossRef citations to date
0
Altmetric
Research Paper

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition

, , , , , , , , , & show all
Pages 649-658 | Published online: 24 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Kristina Riegel & Krishnaraj Rajalingam. (2020) The non-linearity of RAF-MEK signaling in dendritic cells. Cell Cycle 19:18, pages 2249-2259.
Read now
Marta López González, Dinja Oosterhoff, Jelle J. Lindenberg, Ioanna Milenova, Sinead M. Lougheed, Tania Martiáñez, Henk Dekker, Dafne Carolina Alves Quixabeira, Basav Hangalapura, Jos Joore, Sander R. Piersma, Victor Cervera-Carrascon, Joao Manuel Santos, Rik J. Scheper, Henk M.W. Verheul, Connie R. Jiménez, Rieneke Van De Ven, Akseli Hemminki, Victor W. Van Beusechem & Tanja D. De Gruijl. (2019) Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression. OncoImmunology 8:10.
Read now
A Marijne Heeren, Gemma G Kenter, Ekaterina S Jordanova & Tanja D de Gruijl. (2015) CD14+ macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?. OncoImmunology 4:6.
Read now
Lisa K Spary, Josephine Salimu, Jason P Webber, Aled Clayton, Malcolm D Mason & Zsuzsanna Tabi. (2014) Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+ PD-L1+ phenotype in prostate cancer. OncoImmunology 3:9.
Read now
Jelle J. Lindenberg, Rieneke van de Ven, Sinéad M. Lougheed, Anoek Zomer, Saskia JAM Santegoets, Arjan W. Griffioen, Erik Hooijberg, Alfons J.M. van den Eertwegh, Victor L. Thijssen, Rik J. Scheper, Dinja Oosterhoff & Tanja D. de Gruijl. (2013) Functional characterization of a STAT3-dependent dendritic cell-derived CD14+ cell population arising upon IL-10-driven maturation. OncoImmunology 2:4.
Read now

Articles from other publishers (39)

Heng Dong, Qiang Li, Yu Zhang, Meng Ding, Zhaogang Teng & Yongbin Mou. (2023) Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy. Advanced Science 10:18.
Crossref
Eleonora Sosa Cuevas, Philippe Saas & Caroline Aspord. (2023) Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15:8, pages 2206.
Crossref
Enrica Marmonti, Jacqueline Oliva-Ramirez & Cara Haymaker. (2022) Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. Cells 11:19, pages 3028.
Crossref
Jing Jie, Guomu Liu, Jingyue Feng, Desheng Huo, Yixuan Wu, Hongyan Yuan, Guixiang Tai & Weihua Ni. (2022) MF59 Promoted the Combination of CpG ODN1826 and MUC1-MBP Vaccine-Induced Antitumor Activity Involved in the Enhancement of DC Maturation by Prolonging the Local Retention Time of Antigen and Down-Regulating of IL-6/STAT3. International Journal of Molecular Sciences 23:18, pages 10887.
Crossref
Parisa Shiri Aghbash, Milad Shirvaliloo, Ammar Khalo Abass Kasho, Farbod Alinezhad, Hans Nauwynck & Hossein Bannazadeh Baghi. (2022) Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?. International Immunopharmacology 108, pages 108896.
Crossref
Farid Ghorbaninezhad, Zahra Asadzadeh, Javad Masoumi, Ahad Mokhtarzadeh, Tohid Kazemi, Leili Aghebati-Maleki, Siamak Sandoghchian Shotorbani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nima Hemmat, Mohammad Bakhshivand & Behzad Baradaran. (2022) Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside. Life Sciences 297, pages 120466.
Crossref
Yan Mei, Mingdian Wang, Guanming Lu, Jiangchao Li, Lixia Peng, Yanhong Lang, Mingming Yang, Lingbi Jiang, Changzhi Li, Lisheng Zheng, Zhijie Liu, Dehuan Xie, Lingling Guo, Bijun Huang, Musheng Zeng, Yanxia Shi & Chaonan Qian. (2021) Postponing tumor onset and tumor progression can be achieved by alteration of local tumor immunity. Cancer Cell International 21:1.
Crossref
Junfang Li, Xiaoling Hu, Tian Luo, Yingmei Lu, Yiyue Feng, Honghua Zhang, Dan Liu, Xiaohong Fan, Yuqing Wang, Liming Jiang, Yuying Wang, Xiangyong Hao, Tao Shi & Zhen Wang. (2021) N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation. European Journal of Medicinal Chemistry 226, pages 113817.
Crossref
Zhenxing Zhang, Simiao Chen, Menghui Fan, Guojing Ruan, Tao Xi, Lufeng Zheng, Le Guo, Feng Ye & Yingying Xing. (2021) Helicobacter pylori induces gastric cancer via down‐regulating miR‐375 to inhibit dendritic cell maturation . Helicobacter 26:4.
Crossref
Huakan Zhao, Lei Wu, Guifang Yan, Yu Chen, Mingyue Zhou, Yongzhong Wu & Yongsheng Li. (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduction and Targeted Therapy 6:1.
Crossref
Massimo Pancione, Luigi Cerulo, Andrea Remo, Guido Giordano, Álvaro Gutierrez-Uzquiza, Paloma Bragado & Almudena Porras. (2021) Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process. Biomolecules 11:5, pages 629.
Crossref
Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Afshin Derakhshani, Nicola Silvestris, Amir Baghbanzadeh, Vito Racanelli & Behzad Baradaran. (2021) From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past. Frontiers in Immunology 12.
Crossref
Elisabetta Michielon, Marta López González, Judith L. A. Burm, Taco Waaijman, Ekaterina S. Jordanova, Tanja D. de Gruijl & Susan Gibbs. (2020) Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10. Cancer Immunology, Immunotherapy 69:11, pages 2319-2331.
Crossref
Kim M van Pul, Ronald J C L M Vuylsteke, Monique T A de Beijer, Rieneke van de Ven, M Petrousjka van den Tol, Hein B A C Stockmann & Tanja D de Gruijl. (2020) Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway. Journal for ImmunoTherapy of Cancer 8:2, pages e000761.
Crossref
M López González, R van de Ven, H de Haan, J Eck van der Sluijs, W Dong, V W van Beusechem & T D de Gruijl. (2020) Oncolytic adenovirus ORCA-010 increases the type 1 T cell stimulatory capacity of melanoma-conditioned dendritic cells. Clinical and Experimental Immunology 201:2, pages 145-160.
Crossref
Domenico Galati, Serena Zanotta, Giorgio Emanuele Polistina, Antonietta Coppola, Ludovica Capitelli & Marialuisa Bocchino. (2020) Circulating dendritic cells are severely decreased in idiopathic pulmonary fibrosis with a potential value for prognosis prediction. Clinical Immunology 215, pages 108454.
Crossref
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal, Ignacio Melero, Matthew F. Krummel & David Sancho. (2019) Dendritic cells in cancer immunology and immunotherapy. Nature Reviews Immunology 20:1, pages 7-24.
Crossref
Domenico Galati, Serena Zanotta, Angelo Canora, Giorgio E. Polistina, Carmine Nicoletta, Giacomo Ghinassi, Emanuele Ciasullo & Marialuisa Bocchino. (2020) Severe depletion of peripheral blood dendritic cell subsets in obstructive sleep apnea patients: A new link with cancer?. Cytokine 125, pages 154831.
Crossref
Nana Wei, Zhibing Lin, Zhengmao Xu, Haiyan Gong, Houshuang Zhang, Yongzhi Zhou, Jie Cao, Guoqing Li & Jinlin Zhou. (2019) Immunosuppressive effects of tick protein RHcyst-1 on murine bone marrow-derived dendritic cells. Parasites & Vectors 12:1.
Crossref
Prajakta Shinde, Sameer Melinkeri, Manas Kumar Santra, Vaijayanti Kale & Lalita Limaye. (2019) Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients. Frontiers in Immunology 10.
Crossref
Michael J. Gough, Jason R. Baird & R. Bryan Bell. (2018) Implantable biomaterials to provide local immunotherapy following surgical resection. Oncotarget 9:102, pages 37612-37613.
Crossref
Prajakta Shinde, Sophia Fernandes, Sameer Melinkeri, Vaijayanti Kale & Lalita Limaye. (2018) Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy. Scientific Reports 8:1.
Crossref
Andreas Schlitzer, Wei Zhang, Mei Song & Xiaojing Ma. (2018) Recent advances in understanding dendritic cell development, classification, and phenotype. F1000Research 7, pages 1558.
Crossref
Kristian M. Hargadon. (2017) Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma. Frontiers in Immunology 8.
Crossref
Trevor Smith, Xiaotian Lin, Marielle Mello, Kristi Marquardt, Jocelyn Cheung, Binfeng Lu, Linda A. Sherman & Grégory Verdeil. (2017) Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells. The Journal of Immunology 199:8, pages 2713-2720.
Crossref
Zangbéwendé Guy Ouédraogo, Julian Biau, Jean-Louis Kemeny, Laurent Morel, Pierre Verrelle & Emmanuel Chautard. (2016) Role of STAT3 in Genesis and Progression of Human Malignant Gliomas. Molecular Neurobiology 54:8, pages 5780-5797.
Crossref
Carmen Steinborn, Amy Marisa Klemd, Ann-Sophie Sanchez-Campillo, Sophie Rieger, Marieke Scheffen, Barbara Sauer, Manuel Garcia-Käufer, Konrad Urech, Marie Follo, Annekathrin Ücker, Gunver Sophia Kienle, Roman Huber & Carsten Gründemann. (2017) Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model. PLOS ONE 12:7, pages e0181553.
Crossref
Richard Beatson, Virginia Tajadura-Ortega, Daniela Achkova, Gianfranco Picco, Theodora-Dorita Tsourouktsoglou, Sandra Klausing, Matthew Hillier, John Maher, Thomas Noll, Paul R Crocker, Joyce Taylor-Papadimitriou & Joy M Burchell. (2016) The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nature Immunology 17:11, pages 1273-1281.
Crossref
Kristian Hargadon. (2016) Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity. Journal of Clinical Medicine 5:9, pages 76.
Crossref
Jinbao Zong, Anton A. Keskinov, Galina V. Shurin & Michael R. Shurin. (2016) Tumor-derived factors modulating dendritic cell function. Cancer Immunology, Immunotherapy 65:7, pages 821-833.
Crossref
Daniele Vergara, Pasquale Simeone, Julien Franck, Marco Trerotola, Anna Giudetti, Loredana Capobianco, Andrea Tinelli, Claudia Bellomo, Isabelle Fournier, Antonio Gaballo, Saverio Alberti, Michel Salzet & Michele Maffia. (2016) Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics. EuPA Open Proteomics 10, pages 31-41.
Crossref
Saskia Langosch, Rebekka Wehner, Ania Malecka, Hester A. Franks, Knut Schäkel, Michael Bachmann, Andrew M. Jackson & Marc Schmitz. (2016) Impact of p38 mitogen-activated protein kinase inhibition on immunostimulatory properties of human 6-sulfo LacNAc dendritic cells. Immunobiology 221:2, pages 166-174.
Crossref
F. M. Abomaray, M. A. Al Jumah, B. Kalionis, A. S. AlAskar, S. Al Harthy, D. Jawdat, A. Al Khaldi, A. Alkushi, B. A. Knawy & M. H. Abumaree. (2014) Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells. Stem Cell Reviews and Reports 11:3, pages 423-441.
Crossref
A. Marijne Heeren, Bas D. Koster, Sanne Samuels, Debbie M. Ferns, Dafni Chondronasiou, Gemma G. Kenter, Ekaterina S. Jordanova & Tanja D. de Gruijl. (2015) High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer. Cancer Immunology Research 3:1, pages 48-58.
Crossref
Thomas Wurdinger, Katrin Deumelandt, Hans J. van der Vliet, Pieter Wesseling & Tanja D. de Gruijl. (2014) Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: How to break a vicious cycle. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 560-575.
Crossref
Yong Lu, Mingjun Zhang, Siqing Wang, Bangxing Hong, Zhiqiang Wang, Haiyan Li, Yuhuan Zheng, Jing Yang, Richard E. Davis, Jianfei Qian, Jian Hou & Qing Yi. (2014) p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression. Nature Communications 5:1.
Crossref
Jennifer E. Yeh, Patricia A. Toniolo & David A. Frank. (2013) Targeting transcription factors. Current Opinion in Oncology 25:6, pages 652-658.
Crossref
STEFAN LANGHAMMER. (2013) Rationale for the design of an oncology trial using a generic targeted therapy multi-drug regimen for NSCLC patients without treatment options (Review). Oncology Reports 30:4, pages 1535-1541.
Crossref
Zorica Stojić-Vukanić, Biljana Bufan, Nevena Arsenović-Ranin, Duško Kosec, Ivan Pilipović, Milica Perišić Nanut & Gordana Leposavić. (2013) Aging affects AO rat splenic conventional dendritic cell subset composition, cytokine synthesis and T-helper polarizing capacity. Biogerontology 14:4, pages 443-459.
Crossref